(Reuters) - Horizon Pharma Inc said U.S. health regulators approved its experimental drug to treat a broad range of disorders including rheumatoid arthritis.
Horizon said the U.S. Food and Drug Administration approved the drug Rayos to treat inflammatory diseases such as rheumatoid arthritis, polymyalgia rheumatica, psoriatic arthritis, ankylosing spondylitis, asthma and chronic obstructive pulmonary disease.
Rayos, which is a delayed-release formulation of low-dose prednisone, is marketed in Europe as Lodotra to treat moderate to severe rheumatoid arthritis.
The biopharmaceutical company, which went public a year ago, had conducted two trials to establish safety and efficacy of the drug.
(Reporting By Pallavi Ail in Bangalore; Editing by Roshni Menon)
Source: http://news.yahoo.com/fda-approves-horizons-rheumatoid-arthritis-drug-222111670--finance.html
what time does the super bowl start ben gazzara nfl hall of fame 2012 ufc diaz vs condit josephine baker super bowl start time target jason wu
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.